Skip to main content
IDEXX LABORATORIES INC /DE logo

IDEXX LABORATORIES INC /DE — Investor Relations & Filings

Ticker · IDXX ISIN · US45168D1046 LEI · OGMTXK0LUU1HKV2P0J84 US Professional, scientific and technical activities
Open in API
Filings indexed 1,395 across all filing types
Latest filing 2024-05-08 Director's Dealing
Country US United States of America
Listing US IDXX

About IDEXX LABORATORIES INC /DE

https://www.idexx.com/

IDEXX Laboratories, Inc. is a global leader in diagnostics and software for the veterinary, livestock, and water testing markets. The company develops, manufactures, and distributes a broad range of products and services aimed at enhancing the health and well-being of pets, people, and livestock. Core offerings include in-clinic point-of-care diagnostic instruments and tests, a global network of reference laboratories providing advanced testing services, and practice management software solutions for veterinarians. These integrated solutions provide veterinarians with actionable insights to deliver advanced medical care and improve practice efficiency.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2024-05-08 English
10-Q
Interim / Quarterly Report Q1 2024
2024-05-01 English
FORM 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated May 1, 2024, reporting the company's financial results for the quarter ended March 31, 2024. It references a press release titled 'IDEXX Laboratories Announces First Quarter Results' as Exhibit 99.1. The document explicitly states it is furnished under Item 2.02 (Results of Operations and Financial Condition) and clarifies that the information is furnished, not filed, and includes a press release. The length is 4196 characters, which is relatively short and primarily serves as an announcement of quarterly financial results rather than a full detailed report. This matches the characteristics of an Earnings Release (ER), which is an initial announcement of quarterly financial results with key highlights only, rather than a full Interim/Quarterly Report (IR) which would contain substantive financial data and analysis. Therefore, the correct classification is Earnings Release (ER).
2024-05-01 English
ARS
Annual Report
2024-03-27 English
DEFA14A
Remuneration Information Classification · 95% confidence The document is identified as a Schedule 14A filing, which is a Proxy Statement pursuant to Section 14(a) of the Securities Exchange Act of 1934. The text includes terms like 'Proxy Statement,' 'Definitive Additional Materials,' and references to solicitation of votes, which are typical for proxy materials. The document length is short (1052 characters), and it does not contain financial statements or detailed financial data. Therefore, it is not an Annual Report or Management Report but rather falls under Proxy Solicitation & Information Statement filings. The appropriate classification is DEF 14A, which covers remuneration and proxy-related information.
2024-03-27 English
DEF 14A
Proxy Solicitation & Information Statement
2024-03-27 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.